# The Treatment of Tuberculosis in HIV-Infected Patients

> **NCT00001033** · PHASE3 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 650 (—)

## Conditions studied

- HIV Infections
- Tuberculosis

## Interventions

- **DRUG:** Ethambutol hydrochloride
- **DRUG:** Isoniazid
- **DRUG:** Pyrazinamide
- **DRUG:** Pyridoxine hydrochloride
- **DRUG:** Levofloxacin
- **DRUG:** Rifampin

## Key facts

- **NCT ID:** NCT00001033
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 1997-07
- **Target enrollment:** 650 (—)
- **Last updated:** 2021-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001033, "The Treatment of Tuberculosis in HIV-Infected Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00001033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*